Nivolumab,Ipilimumab
BMS
[]
immunotherapy in advanced esophagogastric cancers: one of the most complex topics in all of oncology updates on cm647 and cm648 @ #gi23 asco guidelines recently published controversy inevitable and evolution likely. next, incorporate cldn 18.2! 
Gene Upshaw Memorial Tahoe Forest Cancer Center. Research focus on GI and Endocrine cancers. Rural Oncologist. Avid hiker and runner. Tweets are my own.